Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/7/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Jeffrey A. Lieberman

Wrong Dr. Jeffrey A. Lieberman?


Phone: (703) ***-****  HQ Phone
American Psychiatric Association
1515 Wilson Blvd Suite 800
Arlington, Virginia 22209
United States

Company Description: The American Psychiatric Association is a national medical specialty society whose more than 36,000 physician members specialize in diagnosis, treatment, prevention...   more

Employment History

Board Memberships and Affiliations


  • MD
  • M.D.
  • M.D. 1
  • bachelor's degree , biology
    Miami University of Oxford , Ohio
  • medical degree
    George Washington University
189 Total References
Web References
Interview with Jeffrey ..., 7 June 2014 [cached]
Interview with Jeffrey Lieberman, APA President-Elect
Interview with Jeffrey Lieberman, APA President-Elect
Tomorrow, May 7, Jeffrey A. ..., 6 May 2014 [cached]
Tomorrow, May 7, Jeffrey A. Lieberman, M.D., President, American Psychiatric Association; Lawrence C. Kolb Professor and Chairman of Psychiatry at the Columbia University College of Physicians and Surgeons, and Director of the New York State Psychiatric Institute, will present a summary of the ITI-007-005 trial results in an oral presentation.
Jeffrey Lieberman, M.D. is ..., 25 Mar 2014 [cached]
Jeffrey Lieberman, M.D. is the Lawrence C. Kolb Professor and Chairman of Psychiatry, at the Columbia University College of Physicians and Surgeons; and Director, of the New York State Psychiatric Institute; Psychiatrist-in-Chief, New York Presbyterian Hospital-Columbia University Medical Center.
Antidepressant efficacy, 30 April 2006 [cached]
Dr. Jeffrey Lieberman, a professor of psychiatry and pharmacology at the University of North Carolina, said that the agency's action suggested that antidepressants had become too popular and physicians too casual about dispensing them. Lilly Ferociously Defends Its Top Seller, 9 Sept 2004 [cached]
"I think they're sort of being forced into this by the personal-injury lawyers who now see this as a source of revenue," says Jeffrey Lieberman, a psychiatrist at the University of North Carolina, Chapel Hill, who is conducting a trial comparing major schizophrenia drugs for the National Institutes of Health.
Lieberman conducted pivotal trials on Abilify, a schizophrenia drug from Bristol-Myers Squibb (nyse: BMY) and Otsuka Pharmaceuticals that has made its lack of weight gain a major selling point. But he does not see giving up on Zyprexa yet, even as a first choice. Less than half of patients on the drug gain significant weight, he says, and many physicians are comfortable prescribing it. Instead, he sees drugs with less potential for making patients fat, such as Abilify and Pfizer's (nyse: PFE) Geodon, as options for switching patients who have trouble. Young patients also might benefit, he says, as they are more likely to gain weight on Zyprexa and more likely to stop treatment because of it.
But Lieberman says that decision "flies in the face" of available evidence.
Other People with the name "Lieberman":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.